Infection

Papers
(The H4-Index of Infection is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Emergence of Campylobacter fetus bacteraemias in the last decade, France93
Reply to: Differential diagnosis between Kaposi sarcoma-associated herpesvirus cytokine syndrome and hemophagocytic lymphohistiocytosis77
No link between the prevalence of hepatitis E virus infection and the diagnosis of schizophrenia67
Risk of hemolysis in Plasmodium vivax malaria patients receiving standard primaquine treatment in a population with high prevalence of G6PD deficiency63
Suspected Buruli ulcer cases in Tonkolili District, Sierra Leone– a prospective cohort study54
Immunogenicity and safety of the accelerated 2-dose intradermal rabies pre exposure prophylaxis regimen in immunocompetent and immunocompromised pediatric populations: a comparative study51
Diagnostic nomogram to differentiate between epididymal tuberculosis and bacterial epididymitis49
Rare and risky: a unique case of concurrent chronic pulmonary aspergillosis and lemierre syndrome46
Household transmission of Omicron variant of SARS-CoV-2 under conditions of hybrid immunity—a prospective study in Germany45
Reply to: Challenges in interpreting the role of gentamicin in treatment of invasive listeriosis: immortal timebias and confounding43
Investigation of the pathogen-specific antibody response in periprosthetic joint infection42
Uropathogens and prognosis among patients with hospital-diagnosed acute pyelonephritis: insights from a 19-year population-based cohort study38
Preadmission course and management of severe pediatric group A streptococcal infections during the 2022–2023 outbreak: a single-center experience36
High risk of drug-resistant tuberculosis in IGRA-negative contacts: should preventive treatment be considered?36
Live microbials to boost Anti-SARS-CoV-2 immunity clinical trial (Live BASIC trial): a triple-blind randomized controlled trial35
Horizontal transfer of ΦHKU.vir and its role in the evolution of acapsular emm89 group A Streptococcus in Taiwan34
Diagnostic delay in pulmonary blastomycosis: a case series reflecting a referral center experience34
Emergence and characterization of mixed Candida auris strain infections in China32
Epidemiology and risk factors of community-acquired pneumonia in patients with different causes of immunosuppression32
Diagnosis and management of complicated urogenital schistosomiasis: a systematic review of the literature32
Experience with dalbavancin use in various gram-positive infections within Aberdeen Royal Infirmary OPAT service31
Towards shortening the duration of antibiotic therapy for Lyme borreliosis: a systematic review and meta-analysis30
Treatment outcomes of clofazimine-containing regimens in Mycobacterium avium complex pulmonary disease: a retrospective study from two European reference centers30
Association of stress hyperglycemia ratio and mortality in patients with sepsis: results from 13,199 patients30
Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 and BA.5 subvariant predominance: a systematic literature review29
Efficacy and safety of colistin–doxycycline combination therapy in multi-drug resistance Gram-negative infections: a double-blind randomized controlled trial28
Epidemic cycles and post-epidemic decline of Mycoplasma pneumoniae in Italian children: implications for empirical macrolide prescribing28
Enhancing upper respiratory tract infection detection: exploring qPCR negative respiratory samples using targeted next-generation sequencing28
Blazing the trail for innovative tuberculosis diagnostics28
SARS-CoV-2 infection in technology-dependent children: a multicenter case series28
Outcome of Human Parainfluenza Virus infection in allogeneic stem cell transplantation recipients: possible impact of ribavirin therapy28
0.2471010684967